Last update 01 Nov 2024
Shanghai Xiandai Medicine Preparation Engineering Research Centre Co., Ltd.

Shanghai Xiandai Medicine Preparation Engineering Research Centre Co., Ltd.

Private Company|
1996|
Shanghai Shi, China
|
www.namerc.com.cn

Overview

Tags

Other Diseases
Nervous System Diseases
Congenital Disorders
siRNA
Herbal medicine
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Infectious Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Herbal medicine1
Small molecule drug1
siRNA1
Top 5 TargetCount
EP1(Prostanoid EP1 receptor)1
GSDMD(gasdermin D)1

Related

4
Drugs associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co., Ltd.
Galantamine Hydrobromide
Target
AChE
Mechanism
AChE inhibitors
Active Org.
Janssen, Inc. [+3]
Originator Org.
Janssen Pharmaceuticals, Inc.Janssen Pharmaceuticals, Inc.
Active Indication
Alzheimer Disease
Inactive Indication
Cognitive Dysfunction [+8]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date28 Feb 2001
Alprostadil
Target
EP1
Mechanism
EP1 agonists
Active Org.
Beijing Tide Pharmaceutical Co., Ltd.Beijing Tide Pharmaceutical Co., Ltd. [+9]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
Hepatitis, Chronic [+15]
Inactive Indication
CREST Syndrome [+8]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date16 Oct 1981
Zexie Jiangzhi Capsule
Target-
Mechanism-
Active Org.
Jiangsu Kanion Pharmaceutical Co., Ltd.Jiangsu Kanion Pharmaceutical Co., Ltd. [+1]
Originator Org.-
Active Indication
Hyperlipidemias
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
10
Clinical Trials associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co., Ltd.
CTR20232153 / CompletedPhase 1
泽泻降脂胶囊在中国健康人体内餐后单次给药的药代动力学试验。
[Translation] Pharmacokinetic study of Zexie Jiangzhi Capsule after single postprandial administration in healthy Chinese volunteers.
CTR20231110 / CompletedPhase 1
泽泻降脂胶囊在中国健康人体内连续给药的耐受性和药代动力学试验
[Translation] Tolerability and pharmacokinetics of Zexie Jiangzhi Capsule after continuous administration in healthy Chinese subjects
CTR20212260 / CompletedPhase 1
泽泻降脂胶囊在中国健康人体内空腹单次给药的耐受性和药代动力学试验。
[Translation] Tolerability and pharmacokinetics of a single fasting dose of Zexie Jiangzhi Capsule in healthy Chinese volunteers.
100 Clinical Results associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co., Ltd.
Login to view more data
100 Deals associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 1 Clinical
Phase 2 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Alprostadil
 ( EP1 )		Arteriosclerosis Obliterans
More
Phase 2
Zexie Jiangzhi Capsule
-
Phase 1
GSDMD siRNA(Ruijin Hospital)
 ( GSDMD )		Sepsis
More
Preclinical
Galantamine Hydrobromide
 ( AChE )		Alzheimer Disease
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free